Metabolic syndrome (waist circumference, blood lipids, glucose, blood pressure) goes along with elevated oxidative stress. H₂ was therefore studied as a research subject — not as a therapy.\n\nNakao and colleagues (2010) reported in an open-label pilot with 20 participants on eight weeks of HRW: the antioxidant enzyme SOD increased, the oxidation marker TBARS decreased; HDL also improved. Without a placebo group, such results are vulnerable to expectation and mode effects.\n\nSong and colleagues (2013, Journal of Lipid Research) randomized 68 people with potential metabolic syndrome to HRW or placebo: the HRW group showed lower LDL-cholesterol values and improved HDL function.\n\nAssessment: two small studies pointing in a consistent direction — a trend, not guideline-grade evidence. Lifestyle (movement, nutrition) remains the foundation; HRW does not replace it.
Key claims and evidence
In small human studies, HRW improved oxidative-stress markers in potential metabolic syndrome.
Medical notice (HWG)
This content is for information only and does not replace medical advice, diagnosis or treatment. Effect statements are phrased cautiously and rely on the cited studies; human studies are partly small and preliminary. Food supplements are not a substitute for a balanced diet. Please consult a doctor for health concerns.